Early studies on the role of aberrant DNA methylation in breast cancer focused on increased DNA methylation (DNA hyper-methylation) of CpG islands of key cancer genes, including ESR1 [22] and BRCA1 [23]. This evidence concerns the gene ESR1 and cancer.